Загрузка...
Delayed rejection of MHC class II-disparate skin allografts in mice treated with farnesyltransferase inhibitors
Farnesyltransferase inhibitors (FTIs), developed as anti-cancer drugs, have the potential to modulate immune responses without causing nonspecific immune suppression. We have investigated the possibility that FTIs, by affecting T cell cytokine secretion, can attenuate alloreactive immune responses....
Сохранить в:
| Опубликовано в: : | Transpl Immunol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369389/ https://ncbi.nlm.nih.gov/pubmed/18930822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trim.2008.09.011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|